A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum

Siew Fah Yeo, Yeyan Zhang, David Schafer, Sheldon Campbell, Brian Wong

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A rapid enzymatic fluorometric assay for measuring D-arabinitol in serum was developed using recombinant D-arabinitol dehydrogenase from Candida albicans (rArDH). rArDH was produced in Escherichia coli and purified by dye- ligand affinity chromatography. rArDH was highly specific for D-arabinitol, cross-reacting only with xylitol (4.9%) among all polyols tested. A Cobas Fara II centrifugal autoanalyzer (Roche) was used to measure NADH fluorometrically when rArDH and NAD were added to serum extracts, and D- arabinitol concentrations were calculated from standard curves derived from pooled human serum containing known amounts of D-arabinitol. The method was precise (mean intra-assay coefficients of variation [CVs], 0.8%, and mean inter-assay CVs, 1.6%) and rapid (3.5 min per assay) and showed excellent recovery of added D-arabinitol in serum (mean recovery rate, 101%). The mean and median D-arabinitol/creatinine ratios were 2.74 and 2.23 μM/mg/dl, respectively, for the 11 patients with candidemia compared to 1.14 and 1.23 μM/mg/dl, respectively, for 10 healthy controls (P <0.01). These results confirm earlier studies showing that serum D-arabinitol measurement may help to promptly diagnose invasive candidiasis. The technique shows a significant improvement in terms of accuracy, cost, simplicity, specificity, and speed compared with gas chromatography, mass spectrometry, and earlier enzymatic assays.

Original languageEnglish (US)
Pages (from-to)1439-1443
Number of pages5
JournalJournal of Clinical Microbiology
Volume38
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Enzyme Assays
Serum
D-arabinitol dehydrogenase
NAD
Invasive Candidiasis
Candidemia
Xylitol
arabitol
Candida albicans
Affinity Chromatography
Gas Chromatography-Mass Spectrometry
Creatinine
Coloring Agents
Escherichia coli
Ligands
Costs and Cost Analysis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Yeo, S. F., Zhang, Y., Schafer, D., Campbell, S., & Wong, B. (2000). A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum. Journal of Clinical Microbiology, 38(4), 1439-1443.

A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum. / Yeo, Siew Fah; Zhang, Yeyan; Schafer, David; Campbell, Sheldon; Wong, Brian.

In: Journal of Clinical Microbiology, Vol. 38, No. 4, 2000, p. 1439-1443.

Research output: Contribution to journalArticle

Yeo, SF, Zhang, Y, Schafer, D, Campbell, S & Wong, B 2000, 'A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum', Journal of Clinical Microbiology, vol. 38, no. 4, pp. 1439-1443.
Yeo, Siew Fah ; Zhang, Yeyan ; Schafer, David ; Campbell, Sheldon ; Wong, Brian. / A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum. In: Journal of Clinical Microbiology. 2000 ; Vol. 38, No. 4. pp. 1439-1443.
@article{9d41c3fe8c7549368c7060138c803f6a,
title = "A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum",
abstract = "A rapid enzymatic fluorometric assay for measuring D-arabinitol in serum was developed using recombinant D-arabinitol dehydrogenase from Candida albicans (rArDH). rArDH was produced in Escherichia coli and purified by dye- ligand affinity chromatography. rArDH was highly specific for D-arabinitol, cross-reacting only with xylitol (4.9{\%}) among all polyols tested. A Cobas Fara II centrifugal autoanalyzer (Roche) was used to measure NADH fluorometrically when rArDH and NAD were added to serum extracts, and D- arabinitol concentrations were calculated from standard curves derived from pooled human serum containing known amounts of D-arabinitol. The method was precise (mean intra-assay coefficients of variation [CVs], 0.8{\%}, and mean inter-assay CVs, 1.6{\%}) and rapid (3.5 min per assay) and showed excellent recovery of added D-arabinitol in serum (mean recovery rate, 101{\%}). The mean and median D-arabinitol/creatinine ratios were 2.74 and 2.23 μM/mg/dl, respectively, for the 11 patients with candidemia compared to 1.14 and 1.23 μM/mg/dl, respectively, for 10 healthy controls (P <0.01). These results confirm earlier studies showing that serum D-arabinitol measurement may help to promptly diagnose invasive candidiasis. The technique shows a significant improvement in terms of accuracy, cost, simplicity, specificity, and speed compared with gas chromatography, mass spectrometry, and earlier enzymatic assays.",
author = "Yeo, {Siew Fah} and Yeyan Zhang and David Schafer and Sheldon Campbell and Brian Wong",
year = "2000",
language = "English (US)",
volume = "38",
pages = "1439--1443",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - A rapid, automated enzymatic fluorometric assay for determination of D- arabinitol in serum

AU - Yeo, Siew Fah

AU - Zhang, Yeyan

AU - Schafer, David

AU - Campbell, Sheldon

AU - Wong, Brian

PY - 2000

Y1 - 2000

N2 - A rapid enzymatic fluorometric assay for measuring D-arabinitol in serum was developed using recombinant D-arabinitol dehydrogenase from Candida albicans (rArDH). rArDH was produced in Escherichia coli and purified by dye- ligand affinity chromatography. rArDH was highly specific for D-arabinitol, cross-reacting only with xylitol (4.9%) among all polyols tested. A Cobas Fara II centrifugal autoanalyzer (Roche) was used to measure NADH fluorometrically when rArDH and NAD were added to serum extracts, and D- arabinitol concentrations were calculated from standard curves derived from pooled human serum containing known amounts of D-arabinitol. The method was precise (mean intra-assay coefficients of variation [CVs], 0.8%, and mean inter-assay CVs, 1.6%) and rapid (3.5 min per assay) and showed excellent recovery of added D-arabinitol in serum (mean recovery rate, 101%). The mean and median D-arabinitol/creatinine ratios were 2.74 and 2.23 μM/mg/dl, respectively, for the 11 patients with candidemia compared to 1.14 and 1.23 μM/mg/dl, respectively, for 10 healthy controls (P <0.01). These results confirm earlier studies showing that serum D-arabinitol measurement may help to promptly diagnose invasive candidiasis. The technique shows a significant improvement in terms of accuracy, cost, simplicity, specificity, and speed compared with gas chromatography, mass spectrometry, and earlier enzymatic assays.

AB - A rapid enzymatic fluorometric assay for measuring D-arabinitol in serum was developed using recombinant D-arabinitol dehydrogenase from Candida albicans (rArDH). rArDH was produced in Escherichia coli and purified by dye- ligand affinity chromatography. rArDH was highly specific for D-arabinitol, cross-reacting only with xylitol (4.9%) among all polyols tested. A Cobas Fara II centrifugal autoanalyzer (Roche) was used to measure NADH fluorometrically when rArDH and NAD were added to serum extracts, and D- arabinitol concentrations were calculated from standard curves derived from pooled human serum containing known amounts of D-arabinitol. The method was precise (mean intra-assay coefficients of variation [CVs], 0.8%, and mean inter-assay CVs, 1.6%) and rapid (3.5 min per assay) and showed excellent recovery of added D-arabinitol in serum (mean recovery rate, 101%). The mean and median D-arabinitol/creatinine ratios were 2.74 and 2.23 μM/mg/dl, respectively, for the 11 patients with candidemia compared to 1.14 and 1.23 μM/mg/dl, respectively, for 10 healthy controls (P <0.01). These results confirm earlier studies showing that serum D-arabinitol measurement may help to promptly diagnose invasive candidiasis. The technique shows a significant improvement in terms of accuracy, cost, simplicity, specificity, and speed compared with gas chromatography, mass spectrometry, and earlier enzymatic assays.

UR - http://www.scopus.com/inward/record.url?scp=0342264687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342264687&partnerID=8YFLogxK

M3 - Article

C2 - 10747122

AN - SCOPUS:0342264687

VL - 38

SP - 1439

EP - 1443

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -